Brenner Tumor of Ovary

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
The Effects of Moderate Exercise on Distress, Quality of Life, and Biomarkers of Angiogenesis and Chronic Stress in Ovarian Cancer Survivors
Status:
Recruiting
Last Changed:
Sep 11, 2019
First Changed:
Aug 22, 2018
Disease(s):
Ovarian Cancer
Intervention(s):
Exercise CounselingAerobic ExercisePhysiological SupportQuality-of-Life AssessmentQuestionnaire AdministrationBest Practice
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Status:
Active, not recruiting
Last Changed:
May 5, 2017
First Changed:
Apr 27, 2009
Disease(s):
Fallopian Tube Clear Cell Adenocarcinoma
Intervention(s):
Elesclomol SodiumPaclitaxel
Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy
Status:
Withdrawn
Last Changed:
Dec 31, 2014
First Changed:
Dec 15, 2011
Disease(s):
Fatigue
Intervention(s):
Acetyl-L-Carnitine HydrochloridePlaceboQuestionnaire AdministrationQuality-of-Life Assessment

Connect. Empower. Inspire.